XML 46 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-based Compensation (Tables)
9 Months Ended
Oct. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Classification of Stock-based Compensation

The following table presents the classification of stock-based compensation for the periods indicated:

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Stock-based compensation:

 

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

$

868

 

 

$

360

 

 

$

2,694

 

 

$

1,071

 

Research and development

 

 

17,898

 

 

 

18,741

 

 

 

54,809

 

 

 

53,775

 

Selling, general and administrative

 

 

8,643

 

 

 

9,000

 

 

 

25,293

 

 

 

27,205

 

Total stock-based compensation

 

$

27,409

 

 

$

28,101

 

 

$

82,796

 

 

$

82,051

 

Weighted-Average Assumptions Used to Estimate Fair Value

The following table sets forth the weighted-average assumptions used to estimate the fair value of employee stock purchase plan awards for the periods indicated:

 

 

 

Three Months Ended October 31,

 

 

Nine Months Ended October 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Employee stock purchase plan awards:

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

54

%

 

 

72

%

 

 

56

%

 

 

81

%

Risk-free interest rate

 

 

5.49

%

 

 

3.78

%

 

 

5.11

%

 

 

2.32

%

Expected term (years)

 

 

0.5

 

 

 

0.5

 

 

0.5

 

 

0.5

 

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

 

0

%

Stock Option Activities

The following table summarizes stock option activities for the period indicated:

 

 

 

Option Outstanding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Intrinsic

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

Value Of

 

 

Remaining

 

 

Aggregate

 

 

 

 

 

 

Weighted-

 

 

Average

 

Options

 

 

Contractual

 

 

Intrinsic

 

 

 

 

 

 

Average

 

 

Grant-date

 

Exercised

 

 

Term

 

 

Value

 

 

 

Shares

 

 

Exercise Price

 

 

Fair Value

 

(in thousands)

 

 

(in years)

 

 

(in thousands)

 

Outstanding at January 31, 2023

 

 

484,791

 

 

$

42.18

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(65,188

)

 

 

23.62

 

 

 

 

$

3,418

 

 

 

 

 

 

 

Forfeited

 

 

(926

)

 

 

42.59

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

(1,064

)

 

 

74.33

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at October 31, 2023

 

 

417,613

 

 

 

45.00

 

 

 

 

 

 

 

 

3.68

 

 

$

2,584

 

Exercisable at October 31, 2023

 

 

358,750

 

 

$

46.30

 

 

 

 

 

 

 

 

3.15

 

 

$

1,790

 

Restricted Stock Unit Activities

The following table summarizes restricted stock unit activities for the period indicated:

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

Average

 

 

 

 

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

Unvested at January 31, 2023

 

 

2,573,359

 

 

$

86.81

 

Granted

 

 

1,190,375

 

 

 

71.77

 

Vested

 

 

(969,060

)

 

 

78.11

 

Forfeited

 

 

(128,201

)

 

 

76.31

 

Unvested at October 31, 2023

 

 

2,666,473

 

 

$

83.76